Back to top
more

McKesson (MCK)

(Real Time Quote from BATS)

$588.18 USD

588.18
182,938

+2.44 (0.42%)

Updated Jul 24, 2024 12:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (163 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks.com featured highlights include Sprouts Farmers Market, Molina Healthcare, Atmos Energy and McKesson

by Zacks Equity Research

Sprouts Farmers Market, Molina Healthcare, Atmos Energy and McKesson are part of the Zacks Screen of the Week article.

Catalent (CTLT) Preliminary Q4 Revenues Dampened by Lower Sales

by Zacks Equity Research

Catalent (CTLT) records lower revenues in Biologics segment in its fourth-quarter fiscal 2023, resulting in overall soft preliminary performance.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Sumit Singh headshot

Bet on These 4 Stocks With Exciting Interest Coverage Ratio

by Sumit Singh

A company capable of generating earnings well above its interest expense can withstand financial hardship. SFM, MOH, ATO and MCK are strong enough to meet financial obligations.

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

by Zacks Equity Research

OPKO Health's (OPK) potential in RAYALDEE raises optimism about the stock.

NextGen (NXGN) to Offer AI-Based Patient Engagement Solutions

by Zacks Equity Research

NextGen (NXGN), in alliance with Luma Health, is set to offer AI-enhanced solutions for patient communications to ambulatory organizations nationwide.

Masimo's (MASI) Stork Baby Monitor Now Available Across U.S.

by Zacks Equity Research

The latest U.S. availability of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.

Ritujay Ghosh headshot

5 Defensive Stocks to Buy Amid Lingering Market Volatility

by Ritujay Ghosh

Volatility has gripped Wall Street again. So, investing in defensive stocks like McKesson Corporation (MCK), Entergy Corporation (ETR), PepsiCo, Inc. (PEP), Johnson & Johnson (JNJ) and Atmos Energy Corporation (ATO) is a safe bet.

Here's Why You Should Retain CONMED (CNMD) Stock for Now

by Zacks Equity Research

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

Fresenius Medical's (FMS) New HHD Device to Increase Portability

by Zacks Equity Research

Fresenius Medical (FMS) gets FDA clearance for Versi HD with GuideMe Software, a portable, home hemodialysis device with an easy-to-use graphical interface providing easier training experiences.

NextGen (NXGN) Behavioral Health Suite to Address Mental Health

by Zacks Equity Research

NextGen's (NXGN) Behavioral Health Suite is expected to ease state reporting and enable the secure sharing of patient information across providers.

Should Value Investors Buy McKesson (MCK) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Invest in HealthEquity (HQY) Stock Now

by Zacks Equity Research

HealthEquity's (HQY) strength in HSA raises optimism about the stock.

Masimo's (MASI) PVi Favored by Study for GDFT in Elderly Patients

by Zacks Equity Research

Masimo's (MASI) non-invasive, continuous PVi is expected to reduce cardiopulmonary complications and fluid administered in elderly patients during GI surgery.

Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio

by Zacks Equity Research

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.

Reasons to Retain West Pharmaceutical (WST) Stock for Now

by Zacks Equity Research

West Pharmaceutical's (WST) strength in its proprietary products segment raises optimism about the stock.

Nevro's (NVRO) New Data Supports SCS Therapy for PDN Treatment

by Zacks Equity Research

Nevro's (NVRO) latest 24-month data demonstrates the benefits of high-frequency 10 kHz SCS implant for durable pain relief and significant improvements in patient condition post-implantation.

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how McKesson (MCK) and Medpace (MEDP) have performed compared to their sector so far this year.

McKesson (MCK) & Genpact Extend Tie Up to Improve Workflow

by Zacks Equity Research

McKesson's (MCK) latest partnership extension is likely to transform its finance operations for enhanced service and competitive growth.

AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment

by Zacks Equity Research

The FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely to remove thrombus and embolic material and minimize blood loss via blood recirculation.

Patterson Companies (PDCO) Hits 52-Week High: What's Aiding It?

by Zacks Equity Research

Investors are optimistic about Patterson Companies' (PDCO) broad product line.

West Pharmaceutical (WST) Hits 52-Week High: More Room to Grow?

by Zacks Equity Research

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View

by Zacks Equity Research

Cardinal Health's (CAH) fiscal fourth-quarter results benefit from the Pharmaceutical segment's solid performance.

Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment

by Zacks Equity Research

Nevro's (NVRO) HFX Connect system is expected to treat individual patients per their requirements with 35 pre-programmed customizable plans.

Derek Lewis headshot

3 Stocks to Buy on Recent Dividend Hikes

by Derek Lewis

Dividend hikes reflect a company's commitment to returning value to shareholders, undoubtedly encouraging. And recently, all three of these companies have boosted their payouts.